|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Ichthyosis | |||||
| 2 | More general conditions related to this trial | ||||
| Congenital Abnormalities | |||||
| Infant, Newborn, Diseases | |||||
| Keratosis | |||||
| Skin Abnormalities | |||||
| Skin Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| monolaurin cream | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Monolaurin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Cariostatic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| FDA Office of Orphan Products Development | |||||
| Cellegy Pharmaceuticals | |||||